91ÉçÇø

Quality of TB Care

This course will not be offered in 2024.

Ìý

DESCRIPTION

Poor quality TB care is widespread and is a key driver of the TB epidemic. This course will address the critical need to go beyond coverage and improve quality of TB care in low and middle-income countries.

COURSE DIRECTORS

Madhukar Pai, MD, PhD
Canada Research Chair in Epidemiology & Global Health, 91ÉçÇø
Associate Director, 91ÉçÇø International TB Centre

Zelalem Temesgen, MD
Director, Mayo Clinic Center for Tuberculosis

COURSE FACULTY

• Bruce Agins, MD – UCSF & HealthQual
• Hannah Alsdurf, PhD - University of Ottawa
• Farhana Amanullah, MD - IRD, Pakistan
• Anurag Bhargava, MD - Yenepoya Medical College, India
• Jody Boffa, MSc, PhD - Stellenbosch University, South Africa
• Adithya Cattamanchi, MD – University of California, San Francisco
• Amrita Daftary, PhD, MPH – York University
• Benjamin Daniels, MSc - Georgetown University
• Jishnu Das, PhD - Georgetown University
• Monica Dias, MSc - WHO, Geneva
• Handaa Enkh-Amgalan, MPA - Mongolia
• Jennifer Furin, MD, PhD - Harvard Medical School
• Sophie Huddart, PhD—University of California San Francisco
• Margaret Kruk, MD – Harvard T.H. Chan School of Public Health
• Ada Kwan, PhD, MHS – University of California, San Francisco
• Goodman Makanda - TB Proof & MSF, South Africa
• Chapal Mehra - Survivors Against TB, India
• Lindiwe Mvusi, MBCHB – National Department of Health, South Africa
• Kogie Naidoo, MD - CAPRISA, South Africa
• Zolelwa Sifumba, MBBCh - TB Proof, South Africa
• Guy Stallworthy - Bill & Melinda Gates Foundation
• Ramnath Subbaraman, MD – Tufts University School of Medicine
• Shams Syed, MD, MPH - World Health Organization
• Shibu Vijayan, MD - PATH, India

CONTENT

In order to end TB, we need to increase access to TB care and simultaneously ensure that the care provided is of sufficiently high quality (i.e. care that is safe, effective, patient-centered,
timely, efficient, and equitable). There is plenty of evidence that quality of TB (and TB-HIV coinfection and MDR-TB) care is poor in many settings, and this is a key reason for the high mortality rate seen in LMICs. This means National TB programs need to think beyond coverage of TB services; they need to start measuring and systematically improving quality of TB care in LMICs. This session of leading international experts will:
• Discuss and debate the best approaches to measurement of quality of TB care
• Review data on quality of TB care and factors that drive variation in care
• Explore quality of TB care in private versus public sectors
• Give examples of quality improvement programs in TB as well as other areas of global health (e.g. from HIV/AIDS) that have worked or failed through case study lessons
• Explain the use of quality dashboards, audits and tools, and their likely impact on quality
• Give strategies for understanding and overcoming the pervasive know-do gap, including training, mentoring, incentives, and system-wide changes for high-quality health systems

OBJECTIVES

By the end of the course, participants will be able to:

• Review various approaches to measuring quality of TB care in low-resource settings
• Summarize current evidence on quality of TB care, and give examples of quality improvement programs that have worked or failed
• Describe the role of research in understanding variation in quality, the know-do gap, and provider performance improvement

TARGET AUDIENCE

• National TB Program managers and program implementers
• Clinicians and nurses
• Researchers and academics involved in TB care and prevention
• Funding agencies
• Product development partnerships
• Policy makers and public health implementers
• Community advocates and civil society

ENROLMENT

Maximum 200 participants.

Ìý